BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35682782)

  • 1. Picrasidine I Triggers Heme Oxygenase-1-Induced Apoptosis in Nasopharyngeal Carcinoma Cells via ERK and Akt Signaling Pathways.
    Ho HY; Chen PJ; Chuang YC; Lo YS; Lin CC; Hsieh MJ; Chen MK
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydrocrenatidine extracted from
    Hsieh MC; Lo YS; Chuang YC; Lin CC; Ho HY; Hsieh MJ; Lin JT
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34165177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin-7-O-glucoside inhibits cell proliferation and modulates apoptosis through the AKT signaling pathway in human nasopharyngeal carcinoma.
    Ho HY; Chen PJ; Lo YS; Lin CC; Chuang YC; Hsieh MJ; Chen MK
    Environ Toxicol; 2021 Oct; 36(10):2013-2024. PubMed ID: 34165247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Picrasidine J, a Dimeric β-Carboline-Type Alkaloid from
    Ho HY; Lin CC; Lo YS; Chuang YC; Abomughaid MM; Hsieh MJ
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
    Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer effects of picrasidine I on oral squamous cell carcinoma.
    Yang YT; Hsieh MJ; Chuang YC; Lin CC; Lo YS; Ho HY; Kumar VB; Ko JL
    Environ Toxicol; 2022 Mar; 37(3):627-636. PubMed ID: 34894061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
    Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14-Thienyl methylene matrine (YYJ18), the derivative from matrine, induces apoptosis of human nasopharyngeal carcinoma cells by targeting MAPK and PI3K/Akt pathways in vitro.
    Xie M; Yi X; Wang R; Wang L; He G; Zhu M; Qi C; Liu Y; Ye Y; Tan S; Tang A
    Cell Physiol Biochem; 2014; 33(5):1475-83. PubMed ID: 24854624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway.
    Li W; Ma H; Liu M
    Mol Biotechnol; 2021 Nov; 63(11):1081-1091. PubMed ID: 34236626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways.
    Liu L; Huang P; Wang Z; Chen N; Tang C; Lin Z; Peng P
    BMC Cancer; 2016 Oct; 16(1):813. PubMed ID: 27756261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
    Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
    Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
    Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
    Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
    Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
    Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wogonin induces cross-regulation between autophagy and apoptosis via a variety of Akt pathway in human nasopharyngeal carcinoma cells.
    Chow SE; Chen YW; Liang CA; Huang YK; Wang JS
    J Cell Biochem; 2012 Nov; 113(11):3476-85. PubMed ID: 22689083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways.
    Zhang M; Zhou X; Zhou K
    Int J Mol Med; 2013 Mar; 31(3):621-7. PubMed ID: 23314035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling.
    Huang W; Zeng C; Liu J; Yuan L; Liu W; Wang L; Zhu H; Xu Y; Luo Y; Xie D; Jiang X; Ren C
    Biochem Biophys Res Commun; 2019 Jun; 514(1):64-70. PubMed ID: 31023529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.